You are here: Home FDA Draft Guidance for Monitoring
Document Actions
  • Send this page to somebody
  • Print this page

FDA Draft Guidance for Monitoring

Last modified October 07, 2011 09:05 AM - EST

The FDA has published a draft guidance document regarding the use of a risk-based approach to monitoring.  Click here to see the document.  Of note, results from the CTTI monitoring project were acknowledged within the draft guidance.

This site conforms to the following standards:

  • Powered by Plone, the Open Source Content Management System
  • Section 508
  • WCAG
  • Valid XHTML
  • Valid CSS
  • Usable in any browser

Related Links

Resource Links